Jiangxi Sanxin Medtec Co Ltd
SZSE:300453
Intrinsic Value
Jiang Xi Sanxin Medtec Co., Ltd. engages in the research, development, manufacture, and sale of medical devices. [ Read More ]
The intrinsic value of one
Jiangxi Sanxin Medtec Co Ltd
stock under the Base Case scenario is
9.09
CNY.
Compared to the current market price of 7.39 CNY,
Jiangxi Sanxin Medtec Co Ltd
is
Undervalued by 19%.
Jiangxi Sanxin Medtec Co Ltd's market capitalization is 3.8B CNY.
Jiangxi Sanxin Medtec Co Ltd stock price is 7.39 CNY.
Jiangxi Sanxin Medtec Co Ltd stock price (7.39 CNY) is 19% less than its Intrinsic Value (9.09 CNY).
Jiangxi Sanxin Medtec Co Ltd stock price (7.39 CNY) is 8% less than its DCF Value (8.03 CNY). Open DCF Valuation
Jiangxi Sanxin Medtec Co Ltd stock price (7.39 CNY) is 27% less than its Relative Value (10.15 CNY). Open Relative Valuation
Jiangxi Sanxin Medtec Co Ltd.
Jiangxi Sanxin Medtec Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 18% to 18%.
Jiangxi Sanxin Medtec Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 16% to 15%.
Jiangxi Sanxin Medtec Co Ltd's Revenue has dropped by 3% over the past 12 months.
Jiangxi Sanxin Medtec Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 15%.
Jiangxi Sanxin Medtec Co Ltd has positive Net Income for the last twelve months.
Jiangxi Sanxin Medtec Co Ltd's short-term assets (692m CNY) exceed its short-term liabilties (565m CNY).
Jiangxi Sanxin Medtec Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 18%.
Jiangxi Sanxin Medtec Co Ltd has positive Operating Income for the last twelve months.
Jiangxi Sanxin Medtec Co Ltd's Revenue has been growing by 11% per year for the last 3 years.
Jiangxi Sanxin Medtec Co Ltd's Revenue is forecast to grow at a rate of 15% per year over the next 3 years.
Jiangxi Sanxin Medtec Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (349m CNY) than debt (342m CNY).
Jiangxi Sanxin Medtec Co Ltd has positive three-year average ROIC (Return on Invested Capital): 16%. The company is efficient at using invested capital to generate operating income.
Jiangxi Sanxin Medtec Co Ltd has positive three-year average ROE (Return on Equity): 18%. The company is efficient at transforming stockholders' equity into net income.
Jiangxi Sanxin Medtec Co Ltd has positive Gross Profit for the last twelve months.
Jiangxi Sanxin Medtec Co Ltd has positive Free Cash Flow for the last twelve months.
Jiangxi Sanxin Medtec Co Ltd's long-term assets (2B CNY) exceed its long-term liabilties (784m CNY).
Jiangxi Sanxin Medtec Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.27.
Jiangxi Sanxin Medtec Co Ltd's Altman Z-Score is very high and is equal to 4.56.
Valuation Backtest
Jiangxi Sanxin Medtec Co Ltd
Run backtest to discover the historical profit from buying and selling
Jiangxi Sanxin Medtec Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Jiangxi Sanxin Medtec Co Ltd
Balance Sheet Decomposition
Jiangxi Sanxin Medtec Co Ltd
| Current Assets | 691.8m |
| Cash & Short-Term Investments | 349.2m |
| Receivables | 107.6m |
| Other Current Assets | 235m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 173.4m |
| PP&E | 936.7m |
| Intangibles | 221.7m |
| Other Non-Current Assets | 7.2m |
| Current Liabilities | 565m |
| Accounts Payable | 166.2m |
| Accrued Liabilities | 48.2m |
| Short-Term Debt | 259.8m |
| Other Current Liabilities | 90.7m |
| Non-Current Liabilities | 219.4m |
| Long-Term Debt | 81.9m |
| Other Non-Current Liabilities | 137.5m |
Earnings Waterfall
Jiangxi Sanxin Medtec Co Ltd
|
Revenue
|
1.3B
CNY
|
|
Cost of Revenue
|
-847.3m
CNY
|
|
Gross Profit
|
452.8m
CNY
|
|
Operating Expenses
|
-208.9m
CNY
|
|
Operating Income
|
243.8m
CNY
|
|
Other Expenses
|
-37.2m
CNY
|
|
Net Income
|
206.6m
CNY
|
Free Cash Flow Analysis
Jiangxi Sanxin Medtec Co Ltd
Profitability Score
Profitability Due Diligence
Jiangxi Sanxin Medtec Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Jiangxi Sanxin Medtec Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jiangxi Sanxin Medtec Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Jiangxi Sanxin Medtec Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jiangxi Sanxin Medtec Co Ltd
Shareholder Return
Price
Jiangxi Sanxin Medtec Co Ltd
| Average Annual Return | 25.43% |
| Standard Deviation of Annual Returns | 71.81% |
| Max Drawdown | -95% |
| Market Capitalization | 3.8B CNY |
| Shares Outstanding | 516 587 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Jiangxi Sanxin Medtec Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Jiang Xi Sanxin Medtec Co., Ltd. engages in the research, development, manufacture, and sale of medical devices. The company is headquartered in Nanchang, Jiangxi and currently employs 1,879 full-time employees. The company went IPO on 2015-05-15. The firm's products include five series: syringe series, infusion & transfusion series, catheter tubing series, blood purification series and other series. The firm distributes its products within the domestic markets and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Jiangxi Sanxin Medtec Co Ltd
stock under the Base Case scenario is
9.09
CNY.
Compared to the current market price of 7.39 CNY,
Jiangxi Sanxin Medtec Co Ltd
is
Undervalued by 19%.
You don't have any saved screeners yet
